$1M Awarded to Study Link Between Cardiovascular Risk Reduction and Weight-Loss Drugs by tempuser_767661681 | Apr 30, 2025Studies will identify predictors of cardiovascular risk reduction in people with obesity and heart disease taking GLP-1 medications.
